natgillin/translations-raw huggingface dataset:
However, the possibility of interactions with commonly used medicinal products cannot entirely be excluded.
Vendar pa možnosti pojava interakcij s pogosto uporabljanimi zdravili ni mogoče popolnoma izključiti.
You should not use Cetrotide 0.25 mg if you are already pregnant, or suspect that you might be pregnant, or if you are breast-feeding.
Cetrotida 0, 25 mg ne smete uporabljati, če ste že noseči, ali če sumite, da bi lahko bili noseči ali če dojite.
HOW TO USE CETROTIDE
KAKO UPORABLJATI ZDRAVILO CETROTIDE
Always use cetrotide exactly as your doctor has told you.
Pri uporabi zdravila Cetrotide natančno upoštevajte zdravnikova navodila.
You should check with your doctor if you are not sure.
Če ste negotovi, se posvetujte z zdravnikom ali s farmacevtom.
The following statements apply to Cetrotide 0.25 mg unless otherwise prescribed by your doctor.
Naslednje navedbe se nanašajo na Cetrotide 0, 25 mg, razen če zdravnik ne predpiše drugače.
Please observe these instructions for use, otherwise you will not fully benefit from Cetrotide 0.25 mg.
Prosimo, upoštevajte ta navodila za uporabo, sicer ne boste imeli popolne koristi od Cetrotide 0, 25 mg.
The contents of one vial (0.25 mg Cetrorelix) are to be administered once daily, at 24 h intervals, either in the morning or in the evening.
Vsebino 1 viale (0, 25 mg cetroreliksa) se injicira enkrat dnevno, v 24 urnih časovnih razmakih, bodisi zjutraj ali zvečer.
Administration in the morning:
Injiciranje zjutraj:
Treatment with Cetrotide 0.25 mg should begin on day 5 or 6 of ovarian stimulation (approximately 96 to 120 hours after start of ovarian stimulation) with urinary or recombinant gonadotropins and is to be continued throughout the gonadotropin treatment period including the day of ovulation induction.
Zdravljenje s Cetrotidom 0, 25 mg se mora začeti na 5. ali 6. dan stimulacije jačnikov (približno 96 do 120 ur po začetku stimulacije jajčnikov) z urinskimi ali rekombinantnimi gonadotropini in se mora nadaljevati ves čas zdravljenja z gonadotropini, vključno z dnevom indukcije ovulacije.
Administration in the evening:
Injiciranje zvečer:
Treatment with Cetrotide 0.25 mg should begin on day 5 of ovarian stimulation (approximately 96 to 108 hours after start of ovarian stimulation) with urinary or recombinant gonadotropins and is to be continued throughout the gonadotropin treatment period until the evening prior to the day of ovulation induction.
Zdravljenje s Cetrotidom 0, 25 mg se mora začeti na 5. dan stimulacije jajčnikov (približno 96 do 108 ur po začetku stimulacije jajčnikov) z urinskimi ali rekombinantnimi gonadotropini in se mora nadaljevati ves čas zdravljenja z gonadotropini do večera pred dnevom indukcije ovulacije.
Cetrotide is intended for subcutaneous use, that means given by injection just under the skin.
Cetrotide je namenjen subkutani uporabi, kar pomeni, da se daje v obliki injekcije tik pod kožo.
The first injection of Cetrotide should be supervised by your doctor.
Prvo dajanje injekcije Cetrotide se mora izvesti pod nadzorom vašega zdravnika.
You can carry out the following injections yourself as long as you have been made aware by your doctor of the symptoms that may indicate allergy, the consequences of such a reaction and the need for immediate treatment.
Naslednje injekcije si lahko dajete sami, pod pogojem, da vas je zdravnik seznanil z znaki, ki lahko kažejo na alergijo, s posledicami takšne reakcije, ter o nujnosti takojšnje zdravniške pomoči.
29 Cetrotide 0.25 mg is for injection under the skin of the lower abdominal wall, preferably around the navel.
Cetrotide 0, 25 mg je namenjen za podkožno injiciranje v spodnji del trebušne stene, po možnosti okoli popka.
To minimise local irritation, please select a different injection site each day.
Za zmanjševanje lokalnega draženja, vsak dan izberite različno mesto injiciranja.
Dissolve Cetrotide 0.25 mg powder only with the water contained in the pre-filled syringe.
28 Cetrotide 0, 25 mg prašek raztopljajte samo z vodo, ki je v napolnjeni injekcijski brizgi.
Do not use a Cetrotide 0.25 mg solution if it contains particles or if it is not clear.
Raztopine Cetrotide 0, 25 mg ne uporabite, če vsebuje delce ali ni bistra.
Before you administer Cetrotide yourself, please read the following instructions carefully
Preden si sami injicirate Cetrotide, natančno preberite naslednja navodila
It is important that your hands and all items you use are as clean as possible.
Pomembno je, da so vaše roke in vsi predmeti, ki jih uporabljate, čimbolj čisti.
Lay out on a clean surface everything you need (one vial, one pre-filled syringe, one injection needle with a yellow mark, one injection needle with a grey mark and two alcohol swabs).
Vse, kar potrebujete, položite na čisto podlago (eno vialo, eno napolnjeno injekcijsko brizgo, eno injekcijsko iglo z rumeno oznako, eno injekcijsko iglo s sivo oznako in dve alkoholni blazinici).
Flip off the plastic cover of the vial.
Odtrgajte plastični pokrovček iz viale.
Wipe the aluminium ring and the rubber stopper with an alcohol swab.
Aluminijasti obroč in gumijasti zamašek obrišite z alkoholno blazinico.
Take the injection needle with the yellow mark and remove the wrapping.
Vzemite injekcijsko iglo z rumeno oznako in odstranite ovojnino.
Take the pre-filled syringe and remove the cover.
Vzemite napolnjeno injekcijsko brizgo in odstranite pokrovček.
Put the needle on the syringe and remove the cover of the needle.
Pritrdite iglo na brizgo in odstranite pokrovček z igle.
Push the needle through the centre of the rubber stopper of the vial.
Potisnite iglo skozi sredino gumijastega zamaška na viali.
Inject the water into the vial by slowly pushing the plunger of the syringe.
S počasnim potiskanjem bata brizge injicirajte vodo v vialo.
Leave the syringe on the vial.
Brizgo pustite na viali.
Gently agitate the vial until the solution is clear and without residue.
Nežno stresajte vialo, dokler raztopina ne postane bistra in brez usedline.
Avoid forming bubbles during dissolution.
Pri raztapljanju se izogibajte tvorbi mehurčkov.
Draw the whole contents of the vial into the syringe.
Povlecite celotno vsebino viale v brizgo.
If solution is left in the vial, invert the vial, pull back the needle until the opening of the needle is just inside the stopper.
Če je v viali ostalo še kaj raztopine, jo obrnite na glavo in vlecite iglo nazaj, dokler ni odprtina igle ravno še v zamašku.
If you look from the side through the gap in the stopper, you can control the movement of the needle and the liquid.
Če od strani gledate skozi vrzel v zamašku, lahko nadzorujete gibanje igle in tekočine.
It is important to withdraw the entire contents of the vial.
Pomembno je, da vialo popolnoma izpraznite.
Detach the syringe from the needle and lay down the syringe.
Ločite brizgo od igle in brizgo odložite.
Take the injection needle with the grey mark and remove its wrapping.
Vzemite injekcijsko iglo s sivo oznako in odstranite ovojnino.
Invert the syringe and push the plunger until all air bubbles have been expelled.
Obrnite brizgo na glavo in potiskajte bat, dokler ne iztisnete vseh zračnih mehurčkov.
Do not touch the needle or allow the needle to touch any surface.
Ne dotikajte se igle in pazite, da se igla ne dotakne kakšne površine.
Choose an injection site at the lower abdominal wall, preferably around the navel.
Izberite mesto injiciranja v spodnjem delu trebušne stene, najbolje okoli popka.
Take the second alcohol swab and clean the skin at the injection site.
Vzemite drugo alkoholno blazinico in očistite mesto injiciranja.
Hold the syringe in one hand.
Brizgo držite v eni roki.
Gently pinch up the skin surrounding the site of injection and hold firmly with the other hand.
Kožo okoli mesta injiciranja rahlo stisnite v kožno gubo in jo z drugo roko trdno držite.
Hold the syringe as you would hold a pencil, insert the needle completely into the skin at an angle of about 45 degree.
Držite brizgo kakor bi držali svinčnik in iglo potisnite do konca v kožo pod kotom približno 45°.
Once the needle has been inserted completely, release your grasp of the skin.
Ko je igla popolnoma v koži, spustite kožno gubo.
Pull back gently the plunger of the syringe.
Narahlo potegnite bat iz brizge.
If blood appears continue as described in step 14.
Če se pojavi kri, nadaljujte, kot piše pod točko 14.
If no blood appears, inject the solution slowly by pushing the plunger gently forward.
Če se kri ne pojavi, počasi injicirajte raztopino z rahlim potiskanjem bata.
After all of the solution is injected, withdraw the needle slowly, applying gentle pressure with the alcohol swab on the skin where the needle was inserted.
Ko ste injicirali vso raztopino, počasi izvlecite iglo iz kože in na mesto injiciranja narahlo pritisnite z alkoholno blazinico.
Withdraw the needle at the same angle as it was inserted.
Iglo izvlecite pod istim kotom, kot ste jo potisnili v kožo.
If blood appears, withdraw the needle with the syringe and gently apply pressure to the injection site.
Če se pojavi kri, potegnite iglo z brizgo iz kože in rahlo pritisnite na mesto injiciranja.
Do not use this solution but empty the syringe in a sink.
Te raztopine ne smete uporabiti, temveč jo izlijte v umivalnik.
Start again with step 1.
Ponovno začnite s točko 1.
Use the syringe and needles only once.
Brizgo in igle uporabite samo enkrat.
Dispose of the syringe and needles immediately after use (put the covers on the needles to avoid injury).
Takoj po uporabi brizge in igle zavrzite (na igle namestite pokrovčke, da preprečite poškodbo).
Overdosage of Cetrotide 0.25 mg may result in a prolonged duration of action but is unlikely to be associated with acute toxic effects.
Preveliko odmerjanje Cetrotida 0, 25 mg lahko povzroči podaljšano trajanje delovanja zdravila, vendar je malo verjetno, da bi bilo povezano z akutnimi toksičnimi učinki.
Therefore, in case of overdosage no specific measures are required.
Zato v primeru prevelikega odmerjanja posebni ukrepi niso potrebni.
If you forget to take Cetrotide:
Če ste pozabili vzeti zdravilo Cetrotide
Do not take a double dose to make up for a forgotten dose, please contact your doctor.
Posvetujte se z zdravnikom.
Ideally Cetrotide 0.25 mg should be administered at 24 hours intervals.
Idealno bi morali Cetrotide 0, 25 mg injicirati v 24 urnih časovnih razmakih.
But if you missed to administer Cetrotide 0.25 mg at the right time it is no problem to administer this dose at a different time of the same day.
Če si ne uspete injicirati Cetrotide 0, 25 mg ob pravem času, lahko to storite kadarkoli še isti dan.
Like all medicines, Cetrotide can cause side effects, although not everybody gets them.
Kot vsa zdravila ima lahko tudi zdravilo Cetrotide neželene učinke, ki pa se ne pojavijo pri vseh bolnikih.
Mild and transient reactions may occur at the injection site like reddening, itching, and swelling.
Blage in prehodne reakcije se lahko pojavijo na mestu injiciranja, kot so pordela koža, srbenje in otekanje.
These problems may affect between 1 and 10 patients out of 100 treated.
Te težave se lahko pojavijo pri 1 do 10 bolnicah na 100 bolnic, ki se zdravijo.
Rare cases of severe generalised allergic reactions have also been reported (less than 1 in 1000 patients).
Poročali so o redkih primerih hudih generaliziranih alergijskih reakcij (manj kot 1 na 1. 000 bolnic).
Occasionally systemic side effects, like nausea and headache have been reported (less than 1 in 100 patients).
Občasno so poročali o sistemskih neželenih učinkih, kot sta slabost in glavobol (manj kot 1 na 100 bolnic).
In addition, a single case of pruritus has been reported during treatment with Cetrorelix.
Dodatno so med zdravljenjem s cetroreliksom zabeležili en sam primer srbenja.
Occasionally, stimulation of ovaries with gonadotropins (hormones promoting egg maturation) may lead to a so-called ovarian hyperstimulation syndrome (OHSS).
Občasno lahko stimulacija jajčnikov z gonadotropini (hormoni, ki pospešujejo dozorevanje jajčeca) pripelje do t. i. sindroma hiperstimulacije jajčnikov (OHSS).
Symptoms like abdominal pain, tension, nausea, vomiting, diarrhoea and breathing difficulties may indicate an OHSS.
Znaki, kot so bolečina v trebuhu, napetost, slabost, bruhanje, driska in težave z dihanjem, lahko kažejo na OHSS.
Please inform your doctor immediately, if you feel such symptoms.
Če opazite takšne znake, takoj obvestite zdravnika.
If any of the side effects gets serious, or if you notice any side effects not mentioned in this leaflet, please inform your doctor or pharmacist.
Če katerikoli neželeni učinek postane resen ali če opazite katerikoli neželeni učinek, ki ni omenjen v tem navodilu, obvestite svojega zdravnika ali farmacevta.
HOW TO STORE CETROTIDE
SHRANJEVANJE ZDRAVILA CETROTIDE
Do not use Cetrotide after the expiry date which is stated on the vial after EXP.
Zdravila ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na viali poleg oznake EXP.
The Cetrotide 0.25 mg powder in the vial and the solvent in the pre-filled syringe have the same expiry date.
Cetrotide 0, 25 mg prašek v viali in vehikel v napolnjeni injekcijski brizgi imata enak datum izteka roka uporabnosti.
31 Do not use Cetrotide if the white pellet in the vial has changed in aspect or colour, or if the solvent solution in the vial is no longer clear and colourless or if it contains particles.
Ne uporabljajte zdravila Cetrotide, če se je belim peletam v viali spremenil videz ali barva ali če vehikel v viali ni več bister in brezbarven, ali če vsebuje delce.
If you have any further questions please consult your doctor or pharmacist.
Če imate dodatna vprašanja, se posvetujte s svojim zdravnikom ali farmacevtom.
What Cetrotide contains
Kaj vsebuje zdravilo Cetrotide
The active substance is cetrorelix acetate 0.26 – 0.27 mg, equivalent to 0.25 mg cetrorelix.
Zdravilna učinkovina je cetroreliksijev acetat, 0, 26 – 0, 27 mg, kar ustreza 0, 25 mg cetroreliksa.
The other ingredient is mannitol.
Pomožna snov je manitol.
The solvent is Water for Injections.
Vehikel je voda za injekcije.
Cetrotide 0.25 mg is a powder for solution for injection.
Izgled zdravila Cetrotide in vsebina pakiranja 30 Cetrotide 0, 25 mg je prašek za raztopino za injiciranje.
It is available in packs of one or seven vials.
Na voljo je v škatli z eno ali s sedmimi vialami.
Additionally, for each vial the packs contain
Dodatno vsebuje škatla za vsako vialo še
• one pre-filled syringe with solvent (water for injections) for parenteral use for dissolving the powder in the vial • one injection needle with a yellow mark for injecting the water into the vial and withdrawing the solution from the vial • one injection needle with a grey mark for injecting the solution • two alcohol swabs for cleaning purposes.
• eno napolnjeno injekcijsko brizgo z vehiklom (voda za injekcije) za parenteralno uporabo za raztapljanje praška v viali • eno injekcijsko iglo z rumeno oznako za injiciranje vode v vialo in za odvzem raztopine iz viale • eno injekcijsko iglo s sivo oznako za injiciranje raztopine • dve alkoholni blazinici za čiščenje.
Serono Europe Limited, 56 Marsh Wall, London E14 9TP, United Kingdom
Serono Europe Limited, 56 Marsh Wall, London E14 9TP, Velika Britanija
Baxter Oncology GmBH, Kantstrasse 2, D-33790 Halle, Germany.
Izdelovalec Baxter Oncology GmbH, Kantstrasse 2, D- 33790 Halle, Nemčija
Deutschland Serono GmbH Freisinger Straße 5 D-85716 Unterschleißheim Tel: +49-89-321 56 0
31 Deutschland Serono GmbH Freisinger Straße 5 D- 85716 Unterschleißheim Tel: +49- 89- 321 56 0
Ísland Gróco ehf.
32 Ísland Gróco ehf.
INFORMATION FOR THE USER
33 NAVODILO ZA UPORABO
Cetrotide 3mg powder and solvent for solution for injection
Cetrotide 3 mg prašek in vehikel za raztopino za injiciranje cetroreliksijev acetat
- If any of the side effects gets serious, or you notice any side effects not listed in this leaflet,
- Če katerikoli neželeni učinek postane resen ali če opazite katerikoli neželeni učinek, ki ni
Cetrotide 3 mg inhibits the effects of a natural hormone, called luteinising hormone releasing hormone (LHRH).
Cetrotide 3 mg zavira učinke naravnega hormona, ki se imenuje luteinizirajoči hormon sproščajoči hormon (LHRH).
Cetrotide 3 mg inhibits premature ovulation which is undesirable during hormone treatment for ovarian stimulation as only mature egg cells are suitable for fertilisation.
Cetrotide 3 mg zavira prezgodnjo ovulacijo, ki je nezaželena med hormonskim zdravljenjem za stimulacijo jajčnikov, saj so samo zrele jajčne celice primerne za oploditev.
Cetrotide 3 mg is used to prevent premature ovulation during a controlled ovarian stimulation, followed by oocyte pick-up and assisted reproductive techniques.
Cetrotide 3 mg se uporablja za preprečevanje prezgodnje ovulacije v času kontrolirane stimulacije jajčnikov, ki ji sledijo vsrkanje oocitov in tehnike asistirane reprodukcije.
In clinical trials Cetrotide 3 mg was used with human menopausal gonadotropin (HMG), however, limited experience with recombinant follicle stimulating hormone (FSH) suggested similar efficacy.
V kliničnih študijah so Cetrotide 3 mg uporabljali skupaj s humanim menopavznim gonadotropinom (HMG), vendar pa omejene izkušnje z rekombinantnim folikle stimulirajočim hormonom (FSH) kažejo podobno učinkovitost.
Do not use Cetrotide:
Ne uporabljajte zdravila Cetrotide:
• if you are allergic (hypersensitive) to cetrorelix acetate, exogenous peptide hormones (medicines similar to Cetrotide 3 mg), or any of the other ingredients. • if you are pregnant or breast-feeding • if you have already reached your menopause • if you have a moderate or severe kidney or liver disease.
• če ste alergični na (preobčutljivi za) cetroreliksijev acetat, eksogene peptidne hormone (zdravila, podobna Cetrotide 3 mg) ali katerokoli sestavino zdravila Cetrotide • če ste noseči ali dojite • če ste že v menopavzi • če imate zmerno ali hudo ledvično ali jetrno bolezen.
Take special care with Cetrotide:
Bodite posebno pozorni pri uporabi zdravila Cetrotide
36 During or following hormonal stimulation of the ovaries an ovarian hyperstimulation syndrome can occur.
34 Med ali po hormonski stimulaciji jajčnikov se lahko pojavi sindrom hiperstimulacije jajčnikov.
There is limited experience up to now with the administration of Cetrotide 3 mg during a repeated ovarian stimulation procedure.
Sedanje izkušnje z uporabo Cetrotida 3 mg pri ponovljenem postopku stimulacije ovarijev so omejene.
Therefore you should use Cetrotide 3 mg in repeated cycles only after a careful risk/ benefit evaluation by your doctor.
Zato smete Cetrotide 3 mg v ponavljajočih ciklusih uporabljati samo, če tako presodi vaš zdravnik po natančni oceni razmerja tveganja/ koristi.
You should not use Cetrotide 3 mg if you are already pregnant, or suspect that you might be pregnant, or if you are breast-feeding.
Cetrotide 3 mg ne smete uporabljati, če ste že noseči ali če sumite, da bi lahko bili noseči ali če dojite.
Always use cetrtide exactly as your doctor has told you.
Pri uporabi zdravila Cetrotide natančno upoštevajte zdravnikova navodila.
The following statements apply to Cetrotide 3 mg unless otherwise prescribed by your doctor.
Naslednje navedbe se nanašajo na Cetrotide 3 mg, razen če zdravnik ne predpiše drugače.
Please observe these instructions for use, otherwise you will not fully benefit from Cetrotide 3 mg.
Prosimo, upoštevajte ta navodila za uporabo, sicer ne boste imeli popolne koristi od Cetrotide 3 mg.
The contents of 1 vial (3 mg cetrorelix) are to be administered on day 7 of ovarian stimulation (approximately 132 to 144 hours after start of ovarian stimulation) with urinary or recombinant gonadotropins.
Vsebino 1 viale (3 mg cetroreliksa) se injicira na 7. dan stimulacije ovarijev (približno 132 do 144 ur po začetku ovarijske stimulacije) z urinskimi ali rekombinantnimi gonadotropini.
A single dose of Cetrotide 3 mg results in a duration of action of at least 4 days.
Enkratni odmerek Cetrotide 3 mg deluje najmanj 4 dni.
If the follicle growth does not allow ovulation induction on the fifth day after injection of Cetrotide 3 mg, additionally 0.25 mg cetrorelix (Cetrotide 0.25 mg) should be administered once daily beginning 96 hours after the injection of Cetrotide 3 mg until the day of ovulation induction.
Če rast folikla ne dovoljuje indukcije ovulacije 5. dan po injekciji Cetrotida 3 mg, se mora dodatno uporabljati 0, 25 mg cetroreliksa (Cetrotide 0, 25 mg) enkrat dnevno, s pričetkom 96 ur po injekciji Cetrotide 3 mg, vse do dneva indukcije ovulacije.
You can carry out the following injections yourself as long as you have been made aware by your doctor of the symptoms that may indicate allergy, the consequences of such a reaction and the need for immediate treatment.
Naslednje injekcije si lahko dajete sami, pod pogojem, da vas je zdravnik seznanil z znaki, ki lahko kažejo na alergijo, s posledicami takšne reakcije ter o nujnosti takojšnje zdravniške pomoči.
Cetrotide 3 mg is for injection under the skin of the lower abdominal wall, preferably around the navel.
Za zmanjševanje lokalnega draženja vsak dan izberite različno mesto injiciranja.
37 Dissolve Cetrotide 3 mg powder only with the water contained in the pre-filled syringe.
Cetrotide 3 mg prašek raztopljajte samo z vodo, ki je v napolnjeni injekcijski brizgi.
Do not use a Cetrotide 3 mg solution if it contains particles or if it is not clear.
Raztopine Cetrotida 3 mg ne uporabite, če vsebuje delce ali ni bistra.
Before you administer Cetrotide yourself, please read the following instructions carefully
35 Preden si sami injicirate Cetrotide, natančno preberite naslednja navodila
Hold the syringe as you would hold a pencil, insert the needle completely into the skin at an angle of about 45 degree.
Držite brizgo, kakor bi držali svinčnik in iglo potisnite do konca v kožo pod kotom približno 45°.
If blood appears, withdraw the needle with the syringe and gently apply pressure to the injection site.
Ponovno začnite s točko 1.
38 If you use more Cetrotide than you should
Če ste uporabili večji odmerek zdravila Cetrotide, kot bi smeli
Overdosage of Cetrotide 3 mg may result in a prolonged duration of action but is unlikely to be associated with acute toxic effects.
Preveliko odmerjanje Cetrotide 3 mg lahko povzroči podaljšano trajanje delovanja zdravila, vendar je malo verjetno, da bi bilo povezano z akutnimi toksičnimi učinki.
Like all medicines, Cetrotide can cause side effects, although not everybody gets them.
Kot vsa zdravila, ima lahko tudi zdravilo Cetrotide neželene učinke, ki pa se ne pojavijo pri vseh bolnikih.
Rare cases of severe generalised allergic reactions have also been reported (less than 1 in 1000 patients).
Poročali so o redkih primerih hudih generaliziranih alergijskih reakcij (manj kot 1 na 1000 bolnic).
Occasionally systemic side effects, like nausea and headache have been reported (less than 1 patient in 100).
Občasno so poročali o sistemskih neželenih učinkih, kot sta slabost in glavobol (manj kot 1 na 100 bolnic).
Symptoms like abdominal pain, tension, nausea, vomiting, diarrhoea and breathing difficulties may indicate an OHSS.
Znaki kot so bolečina v trebuhu, napetost, slabost, bruhanje, driska in težave z dihanjem, lahko kažejo na OHSS.
If you notice any side effects gets serious, or if you notice any side effects not mentioned in this leaflet, please inform your doctor or pharmacist.
Če katerikoli neželeni učinek postane resen ali če opazite katerikoli neželeni učinek, ki ni omenjen v tem navodilu, obvestite svojega zdravnika ali farmacevta.
The Cetrotide 3 mg powder in the vial and the solvent in the pre-filled syringe have the same expiry date.
Cetrotide 3 mg prašek v viali in vehikel v napolnjeni injekcijski brizgi imata enak datum izteka roka uporabnosti.
Do not use Cetrotide if the white pellet in the vial has changed in aspect or colour, or if the solvent solution in the vial is no longer clear and colourless or if it contains particles.
Ne uporabljajte zdravila Cetrotide, če se je belim peletam v viali spremenil videz ali barva ali če vehikel v viali ni več bister in brezbarven, ali če vsebuje delce.
The active substance is cetrorelix acetate 3.12 – 3.24 mg, equivalent to 3 mg cetrorelix.
Zdravilna učinkovina je cetroreliksijev acetat, 3, 12 – 3, 24 mg, kar ustreza 3 mg cetroreliksa.
Cetrotide 3mg is a powder for solution for injection.
Cetrotide 3 mg je prašek za raztopino za injiciranje.